CN111658752A - Medicine for treating diseases caused by novel coronavirus - Google Patents

Medicine for treating diseases caused by novel coronavirus Download PDF

Info

Publication number
CN111658752A
CN111658752A CN202010504504.2A CN202010504504A CN111658752A CN 111658752 A CN111658752 A CN 111658752A CN 202010504504 A CN202010504504 A CN 202010504504A CN 111658752 A CN111658752 A CN 111658752A
Authority
CN
China
Prior art keywords
herb
ginger
rhizome
novel coronavirus
fried
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010504504.2A
Other languages
Chinese (zh)
Inventor
金敏
陶鹤
胡月香
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010504504.2A priority Critical patent/CN111658752A/en
Publication of CN111658752A publication Critical patent/CN111658752A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233—Bupleurum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/268—Asarum (wild ginger)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/532—Agastache, e.g. giant hyssop
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/884—Alismataceae (Water-plantain family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8888—Pinellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/894—Dioscoreaceae (Yam family)
    • A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8998—Hordeum (barley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the technical field of traditional Chinese medicine formulas, and discloses a medicine for treating diseases caused by novel coronavirus, which comprises mix-fried ephedra herb, almond, wrinkled gianthyssop herb, fortune eupatorium herb, tangerine peel, cassia twig, oriental waterplantain rhizome, polyporus, largehead atractylodes rhizome, Indian buead, baical skullcap root, ginger processed pinellia tuber, ginger, aster, common coltsfoot flower, blackberry lily, manchurian wildginger, common yam rhizome, immature bitter orange, mix-fried licorice root and; the invention also discloses application of the medicine for treating diseases caused by the novel coronavirus in preparation of medicines for treating pneumonia and respiratory diseases. The traditional Chinese medicine composition disclosed by the invention is optimized and fused by utilizing a plurality of traditional Chinese medicines, is applied together, achieves a good effect in clinical application, mainly has the effects of clearing lung, expelling toxin, enhancing dampness and relieving cough and phlegm, arresting sweating, relieving cough, invigorating spleen, relieving flatulence and stimulating appetite, and also has the effects of relieving cough and reducing sputum.

Description

Medicine for treating diseases caused by novel coronavirus
Technical Field
The invention relates to the technical field of traditional Chinese medicine formulas, in particular to a medicine for treating diseases caused by novel coronavirus.
Background
The 2019 coronavirus is also called COVID-19 and is a new coronavirus strain discovered in human bodies in 2019. People infected with the virus may develop symptoms of varying degrees, some of which are fever or mild cough, and severe persons after the progression of the disease course manifest as acute respiratory distress syndrome, septic shock, metabolic acidosis and blood coagulation dysfunction which are difficult to correct. In the process of COVID-19 epidemic prevention treatment, the traditional Chinese medicine therapy provides a new clinical evidence diagnosis and treatment idea for medical workers on the epidemic prevention and control front line, the COVID-19 is divided into light, common, heavy and dangerous stages, and different traditional Chinese medicine prescriptions are given at different stages for treatment, so that great contribution is made to the treatment of the COVID-19.
Disclosure of Invention
Based on the above problems, the present invention provides a medicine for treating diseases caused by novel coronavirus, which has the effects of clearing lung, expelling toxin and enhancing dampness.
In order to solve the technical problems, the invention provides the following technical scheme:
a medicine for treating diseases caused by coronavirus comprises herba Ephedrae, semen Armeniacae amarum, herba Agastaches, herba Eupatorii, pericarpium Citri Tangerinae, ramulus Cinnamomi, Alismatis rhizoma, Polyporus, Atractylodis rhizoma, Poria, Scutellariae radix, ginger processed pinellia Tuber, rhizoma Zingiberis recens, radix Asteris, flos Farfarae, rhizoma Belamcandae, herba asari, rhizoma Dioscoreae, fructus Aurantii Immaturus, radix Glycyrrhizae Preparata, and bupleuri radix.
Further, the Chinese magnoliavine fruit and malt porridge further comprises the Chinese magnoliavine fruit, fried medicated leaven, fried hawthorn and fried malt, wherein the mass of each component is as follows: 9g of mix-fried ephedra herb, 9g of almond, 9g of wrinkled gianthyssop herb, 9g of fortune eupatorium herb, 9g of tangerine peel, 9g of cassia twig, 9g of oriental waterplantain rhizome, 9g of polyporus umbellatus, 15g of largehead atractylodes rhizome, 15g of Indian buead, 9g of Chinese thorowax root, 9g of baical skullcap root, 9g of ginger processed pinellia tuber, 9g of ginger, 12g of aster, 12g of common coltsfoot flower, 9g of blackberry lily, 3g of manchurian wildginger, 15g of Chinese yam, 6g of immature bitter orange, 9g of Chinese magnolia.
Further, the gypsum plaster comprises gypsum, and the mass of each component is as follows: 6g of mix-fried ephedra herb, 9g of almond, 9g of dried orange peel, 6g of immature bitter orange, 15g of gypsum, 9g of cassia twig, 9g of rhizoma alismatis, 9g of polyporus umbellatus, 15g of bighead atractylodes rhizome, 15g of poria cocos, 9g of radix bupleuri, 9g of radix scutellariae, 9g of ginger processed pinellia tuber, 9g of ginger, 9g of aster, 9g of flos farfarae, 9g of blackberry lily, 3g of asarum, 21g of Chinese yam, 9g of wrinkled gianthyssop herb, 9g of eupatorium and 6 g.
In order to solve the technical problems, the invention also provides application of the medicine for treating diseases caused by the novel coronavirus in preparation of medicines for treating pneumonia and respiratory diseases.
Compared with the prior art, the invention has the beneficial effects that: the traditional Chinese medicine composition has the advantages that multiple traditional Chinese medicines are optimally fused and applied together, a good effect is achieved in clinical application, the main effects of clearing lung and expelling toxin and enhancing dampness, and the traditional Chinese medicine composition also has the effects of relieving cough and reducing sputum, arresting sweating and relieving cough, tonifying spleen and relieving flatulence and stimulating appetite; the traditional Chinese medicine composition can improve the body resistance, improve the respiratory tract and the whole body symptoms of a patient, relieve the adverse reaction of antiviral western medicines, has the effect of promoting the absorption of the pulmonary inflammation, can effectively improve the prognosis of the patient, promotes the rehabilitation, and plays a positive role in early intervention and treatment.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is further described in detail below with reference to examples, and the exemplary embodiments and descriptions thereof are only used for explaining the present invention and are not used as limitations of the present invention.
Example 1:
a medicine for treating diseases caused by coronavirus comprises herba Ephedrae, semen Armeniacae amarum, herba Agastaches, herba Eupatorii, pericarpium Citri Tangerinae, ramulus Cinnamomi, Alismatis rhizoma, Polyporus, Atractylodis rhizoma, Poria, Scutellariae radix, ginger processed pinellia Tuber, rhizoma Zingiberis recens, radix Asteris, flos Farfarae, rhizoma Belamcandae, herba asari, rhizoma Dioscoreae, fructus Aurantii Immaturus, radix Glycyrrhizae Preparata, and bupleuri radix; the medicine can also be used for preparing combined medicines for treating pneumonia and respiratory system diseases.
Example 2:
the medicine for treating diseases caused by the novel coronavirus comprises the following components in parts by mass: 9g of mix-fried ephedra herb, 9g of almond, 9g of wrinkled gianthyssop herb, 9g of fortune eupatorium herb, 9g of tangerine peel, 9g of cassia twig, 9g of oriental waterplantain rhizome, 9g of polyporus umbellatus, 15g of largehead atractylodes rhizome, 15g of Indian buead, 9g of Chinese thorowax root, 9g of baical skullcap root, 9g of ginger processed pinellia tuber, 9g of ginger, 12g of aster, 12g of common coltsfoot flower, 9g of blackberry lily, 3g of manchurian wildginger, 15g of Chinese yam, 6g of immature bitter orange, 9g of Chinese magnolia.
The drug of this example is suitable for patients with the following symptoms: intermittent cough with cough-phlegm, which is mainly in daytime and white sticky phlegm, with profuse sweating throughout the body at night, slight muscular soreness, abdominal distension and poor appetite, and almost normal stool and urine. The medicine formula of the embodiment has the main effects of relieving cough, reducing phlegm, clearing lung, expelling toxin, enhancing dampness, arresting sweating, relieving cough, strengthening spleen, relieving flatulence and stimulating appetite. The above medicinal materials are decocted with water 400ml, and taken warm after 200ml meals respectively in the morning and evening.
The formula of the embodiment can also be applied to preparation of combined medicines for treating pneumonia and respiratory diseases.
Example 3:
the medicine for treating diseases caused by the novel coronavirus comprises the following components in parts by mass: 6g of mix-fried ephedra herb, 9g of almond, 9g of tangerine peel, 6g of immature bitter orange, 15g of gypsum, 9g of cassia twig, 9g of rhizoma alismatis, 9g of polyporus umbellatus, 15g of bighead atractylodes rhizome, 15g of poria cocos, 9g of radix bupleuri, 9g of scutellaria baicalensis, 9g of ginger processed pinellia tuber, 9g of ginger, 9g of aster, 9g of flos farfarae, 9g of blackberry lily, 3g of asarum, 21g of Chinese yam, 9g of wrinkled gianthyssop herb, 9g of eupatorium and 6.
The drug of this example is suitable for patients with the following symptoms: the patient is admitted with three days of cough as chief complaints, the patient has no obvious symptoms of cough, expectoration, accidental nasal obstruction, fever, hypodynamia and the like, diet and sleep are enough, the patient defecates three times yesterday, wherein one time is yellow soft stool, the other two times are pasty, and the urine is normal; the inferior limitation of the right lung medial lobe pleura rubs the vitreous nodule shadow, the right oblique pleural region abnormal density shadow, the patient has diarrhea. The formula of the medicine provided by the embodiment mainly has the effects of clearing lung, expelling toxin and enhancing dampness. The above medicinal materials are decocted with water 400ml, and taken warm 40min after meal in the morning and evening 200ml each day.
The formula of the embodiment can also be applied to preparation of combined medicines for treating pneumonia and respiratory diseases.
The above is an embodiment of the present invention. The embodiments and specific parameters in the embodiments are only for the purpose of clearly describing the verification process of the invention and are not used to limit the scope of the invention, which is defined by the claims, and all the equivalent structural changes made by using the content of the specification of the invention should be included in the scope of the invention.

Claims (4)

1. The medicine for treating diseases caused by the novel coronavirus is characterized by comprising roasted ephedra, almond, wrinkled gianthyssop herb, fortune eupatorium herb, dried orange peel, cassia twig, oriental waterplantain rhizome, umbellate pore fungus, largehead atractylodes rhizome, Indian buead, baical skullcap root, ginger processed pinellia tuber, ginger, aster, common coltsfoot flower, blackberry lily rhizome, manchurian wildginger, common yam rhizome, immature bitter orange, roasted liquorice and Chinese thorowax root.
2. The medicament for treating diseases caused by the novel coronavirus according to claim 1, further comprising schisandra chinensis, fried medicated leaven, fried hawthorn and fried malt, wherein the mass of each component is as follows: 9g of mix-fried ephedra herb, 9g of almond, 9g of wrinkled gianthyssop herb, 9g of fortune eupatorium herb, 9g of tangerine peel, 9g of cassia twig, 9g of oriental waterplantain rhizome, 9g of polyporus umbellatus, 15g of largehead atractylodes rhizome, 15g of Indian buead, 9g of Chinese thorowax root, 9g of baical skullcap root, 9g of ginger processed pinellia tuber, 9g of ginger, 12g of aster, 12g of common coltsfoot flower, 9g of blackberry lily, 3g of manchurian wildginger, 15g of Chinese yam, 6g of immature bitter orange, 9g of Chinese magnolia.
3. The medicament for treating diseases caused by the novel coronavirus according to claim 1, further comprising gypsum, wherein the mass of each component is as follows: 6g of mix-fried ephedra herb, 9g of almond, 9g of tangerine peel, 6g of immature bitter orange, 15g of gypsum, 9g of cassia twig, 9g of rhizoma alismatis, 9g of polyporus umbellatus, 15g of bighead atractylodes rhizome, 15g of poria cocos, 9g of radix bupleuri, 9g of scutellaria baicalensis, 9g of ginger processed pinellia tuber, 9g of ginger, 9g of aster, 9g of flos farfarae, 9g of blackberry lily, 3g of asarum, 21g of Chinese yam, 9g of wrinkled gianthyssop herb, 9g of eupatorium and 6.
4. Use of a medicament according to any one of claims 1 to 3 for the treatment of a disease caused by a novel coronavirus in the preparation of a medicament for the treatment of a disease associated with pneumonia and respiratory diseases.
CN202010504504.2A 2020-06-05 2020-06-05 Medicine for treating diseases caused by novel coronavirus Pending CN111658752A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010504504.2A CN111658752A (en) 2020-06-05 2020-06-05 Medicine for treating diseases caused by novel coronavirus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010504504.2A CN111658752A (en) 2020-06-05 2020-06-05 Medicine for treating diseases caused by novel coronavirus

Publications (1)

Publication Number Publication Date
CN111658752A true CN111658752A (en) 2020-09-15

Family

ID=72386192

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010504504.2A Pending CN111658752A (en) 2020-06-05 2020-06-05 Medicine for treating diseases caused by novel coronavirus

Country Status (1)

Country Link
CN (1) CN111658752A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112666281A (en) * 2020-12-03 2021-04-16 广东志道医药科技有限公司 Production method of lung-clearing and toxin-expelling soup established based on fingerprint model
CN112675282A (en) * 2021-02-02 2021-04-20 王忠兰 Composition for treating pneumonia, preparation method and particles prepared by composition
CN112891485A (en) * 2020-12-28 2021-06-04 新疆医科大学 Traditional Chinese medicine composition for treating neocoronary pneumonia
CN113398219A (en) * 2021-06-30 2021-09-17 广州白云山星群(药业)股份有限公司 Application of exocarpium citri rubrum extract for preparing medicine for inhibiting human coronavirus infection

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112666281A (en) * 2020-12-03 2021-04-16 广东志道医药科技有限公司 Production method of lung-clearing and toxin-expelling soup established based on fingerprint model
CN112891485A (en) * 2020-12-28 2021-06-04 新疆医科大学 Traditional Chinese medicine composition for treating neocoronary pneumonia
CN112675282A (en) * 2021-02-02 2021-04-20 王忠兰 Composition for treating pneumonia, preparation method and particles prepared by composition
CN113398219A (en) * 2021-06-30 2021-09-17 广州白云山星群(药业)股份有限公司 Application of exocarpium citri rubrum extract for preparing medicine for inhibiting human coronavirus infection

Similar Documents

Publication Publication Date Title
CN111658752A (en) Medicine for treating diseases caused by novel coronavirus
CN100496586C (en) Medicinal liquor for treating hyperosteogency and koilorrhachic
CN111920923A (en) A medicine for treating diseases caused by coronavirus
CN104173704A (en) Traditional Chinese medicine decoction for treating subacute thyroiditis
CN103977368A (en) Traditional Chinese medicinal composition for treating arthralgia caused by rheumatic chills and fever and preparation method thereof
CN104958448A (en) Medicine for treating puerperal infection
CN104491802A (en) Application of traditional Chinese medicine preparation in preparation of medicine for treating acute or chronic gastritis
CN115770279B (en) Traditional Chinese medicine composition for treating chronic lower limb vein diseases, decoction and preparation thereof
CN101249255B (en) Proprietary Chinese medicine for curing children's cough and method of preparing the same
CN1060368C (en) Traditional Chinese medicine Jinjiangkebao for treating cough
CN104189784A (en) Traditional Chinese medicine preparation for aphtha and preparation method of traditional Chinese medicine preparation
CN101129864A (en) Traditional Chinese medicine for treating tonicity headache
CN106267028A (en) A kind of Chinese medicine composition treating pneumonia and preparation method thereof
CN1094057C (en) Liver ascites treating medicine
CN104623217A (en) Traditional Chinese medicine preparation for treating asthma and preparation method thereof
CN104189770A (en) Pharmaceutical composition for treating tuberculous pleuritis and preparation method thereof
CN103494939A (en) Traditional Chinese medicine for treating senile habitual constipation
CN112791164B (en) Traditional Chinese medicine preparation for treating respiratory system infectious diseases
CN102961555B (en) Traditional Chinese medicine composition for treating liver diseases and preparation method for same
CN103212033B (en) Drug composition for treating viral hepatitis
CN114796434A (en) Pill for keeping healthy qi and pathogenic factors dry
CN108144037B (en) Traditional Chinese medicine composition for treating cough and application thereof
CN105106405A (en) Traditional Chinese medicine for treating allergic eczema
CN105079717A (en) Pharmaceutical preparation for treating depression
CN104800573A (en) Chinese medicinal composition for treating liver cancer and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200915

RJ01 Rejection of invention patent application after publication